Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected403 Forbidden error now appears on the page, replacing the expected study details with a generic error screen and a Home option. The study record is currently inaccessible on ClinicalTrials.gov.SummaryDifference21%

- Check19 days agoChange DetectedUpdated the label for locating contact information from 'Find Contact Information' to 'Find contact information' to align with the page's capitalization style. The release version was bumped from v3.6.6 to v3.7.0.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6. This change is a backend revision with no impact on the visible study details.SummaryDifference0.0%

- Check40 days agoChange DetectedNew recruitment sites and investigators were added to the study record, expanding listed locations and contacts. An NIH grant/contract entry was added, and an existing investigator entry was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedNew recruitment sites and contacts were added, including Hospital Santa Izabel in Salvador, Brazil (Clarissa Mathias) and KLES Dr. Prabhakar Kore Hospital & Medical Research Centre (Rohan Bhise), along with associated investigators and phone numbers; older entries for these sites were removed or updated.SummaryDifference0.1%

- Check75 days agoChange DetectedThe site revision has been updated to v3.6.4, replacing v3.6.3, indicating a backend/UI update without changing the study details presented on the page.SummaryDifference0.0%

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.